Systemic immunomodulatory therapies are the principal means of managing non-infectious uveitis. This review aims to explore the current landscape of systemic uveitis treatments, including biologic therapies and the advent of biosimilar therapies.
Keywords: Biologics; Biosimilars; Interferon; Interleukins; Non-infectious uveitis; TNFα inhibitors.